These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Systemic and adjuvant therapy for patients with pancreatic carcinoma. Clark JW; Glicksman AS; Wanebo HJ Cancer; 1996 Aug; 78(3 Suppl):688-93. PubMed ID: 8681308 [TBL] [Abstract][Full Text] [Related]
23. Update on the management of pancreatic cancer: surgery is not enough. Ansari D; Gustafsson A; Andersson R World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
25. Pancreatic Cancer Stem Cells and Therapeutic Approaches. Ercan G; Karlitepe A; Ozpolat B Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612 [TBL] [Abstract][Full Text] [Related]
26. Treatment options for advanced pancreatic cancer: a review. Warsame R; Grothey A Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620 [TBL] [Abstract][Full Text] [Related]
27. Management of advanced pancreatic cancer. Li J; Podoltsev N; Saif MW Expert Rev Clin Pharmacol; 2009 Sep; 2(5):527-41. PubMed ID: 22112226 [TBL] [Abstract][Full Text] [Related]
28. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. Goel G; Sun W J Hematol Oncol; 2015 May; 8():44. PubMed ID: 25935754 [TBL] [Abstract][Full Text] [Related]
31. Combinational therapy: new hope for pancreatic cancer? Shi S; Yao W; Xu J; Long J; Liu C; Yu X Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436 [TBL] [Abstract][Full Text] [Related]
32. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
35. Surgical options in the management of pancreatic cancer. Hackert T; Büchler MW; Werner J Minerva Chir; 2009 Oct; 64(5):465-76. PubMed ID: 19859037 [TBL] [Abstract][Full Text] [Related]
36. Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value. Ahn DH; Ko AH; Meropol NJ; Bekaii-Saab TS Am Soc Clin Oncol Educ Book; 2015; ():e222-7. PubMed ID: 25993177 [TBL] [Abstract][Full Text] [Related]
37. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Blanco VM; Latif T; Chu Z; Qi X Transl Oncol; 2015 Jun; 8(3):196-203. PubMed ID: 26055177 [TBL] [Abstract][Full Text] [Related]
38. Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options. Diwakarla C; Hannan K; Hein N; Yip D World J Gastroenterol; 2017 Apr; 23(13):2276-2285. PubMed ID: 28428707 [TBL] [Abstract][Full Text] [Related]
39. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies. Matera R; Saif MW Expert Opin Emerg Drugs; 2017 Sep; 22(3):223-233. PubMed ID: 28783977 [TBL] [Abstract][Full Text] [Related]